ライフサイエンスコーパス: low molecular weight compound

1 spectrometry (MALDI-MS) for the analysis of low molecular weight compounds.

2 ancers, in particular blocking Siglec-7 with low molecular weight compounds.

3 ge is much larger than the one observed with low molecular weight compounds.

4 o chemical signaling with the plant host via low-molecular-weight compounds.

5 -1 entry and is susceptible to inhibition by low-molecular-weight compounds.

6 finity of the small molecule, which can be a low-molecular-weight compound, a peptide or a nucleic ac

7 These low molecular weight compounds activated glycogen syntha

8 Recently, we found that different low molecular weight compounds, all known to stabilize p

9 This low molecular weight compound also caused apoptotic deat

10 ed drug design exploits initial screening of low molecular weight compounds and their concomitant aff

11 The mobility of a series of low molecular weight compounds and three small peptides

12 Low molecular weight compounds are more permeable wherea

13 m the analysis to be correct for mixtures of low-molecular-weight compounds as well as for mixtures o

14 These low-molecular-weight compounds block EGF-induced EGFR ac

15 symmetric squaric acid bisamides with either low molecular weight compounds but also biomolecules or

16 ity could be released from NAH as a reactive low molecular weight compound by a number of denaturing

17 Release of fixed carbon as low molecular weight compounds by freshly isolated symbi

18 es that are suitable for in situ analysis of low molecular-weight compounds by matrix-assisted laser

19 ular gels are formed by the self-assembly of low-molecular weight compounds by weak non-covalent inte

20 These studies demonstrate that low-molecular-weight compounds can induce conformational

21 nalyses was used to determine changes in the low-molecular-weight compound composition of peanuts due

22 Finally, the low molecular weight compound diclofenac was bound to th

23 This is because low molecular weight compounds do not have sufficient ma

24 or the analysis of free fatty acids or other low-molecular weight compounds during drug discovery and

25 uzain-ligand interactions for a set of eight low-molecular weight compounds exhibiting micromolar bin

26 ction of an analyte group comprising similar low-molecular weight compounds exhibiting the benefits o

27 Focusing on low-molecular-weight compounds (fragments) can dramatica

28 ocol describes the screening of a library of low-molecular-weight compounds (fragments) using a serie

29 olecular imaging of exogenous and endogenous low molecular weight compounds from fingerprints.

30 when allergens were tested together with the low molecular weight compounds from pollen.

31 olomics to perform quantitative profiling of low-molecular weight compounds from biological specimens

32 f QD-based immunoassays for the detection of low molecular weight compounds given the relevance of th

33 In the past year, three low molecular weight compounds have been developed that

34 Siderophores-soluble, low molecular weight compounds-have an easily understood

35 fermentation, with a concurrent increase in low-molecular-weight compounds (hydroxybenzoic and hydro

36 s a new technique for high-speed analysis of low molecular weight compounds in areas such as metaboli

37 ell suited for the analysis of low-polarity, low-molecular weight compounds in powdered, solid, or di

38 The limit of detection of low-molecular weight compounds in tissue sections, analy

39 previously derived for the mass transfer of low-molecular-weight compounds in RPLC.

40 modulating protein-protein interactions with low-molecular-weight compounds is extremely difficult du

41 We report the synthesis and evaluation of 3 low-molecular-weight compounds labeled with (86)Y for im

42 Screening of libraries of non-peptide low molecular weight compounds led to the identification

43 Compared to low-molecular-weight compounds, little information is av

44 at unravelling the antioxidative capacity of low molecular weight compounds (LMWC) (peptides, amino a

45 The resulting low molecular weight compounds (< 475) have one or no ch

46 s able to detect low submicrogram amounts of low molecular weight compounds (<500 Da).

47 bstituent allowed N-terminal truncation to a low-molecular-weight compound (<600 Da) that effectively

48 ST-246 is a low-molecular-weight compound (molecular weight = 376),

49 es for the best compounds were high for such low molecular weight compounds (MW < 500) with EC(50) va

50 ters and fragment peaks that mask signals of low molecular weight compounds of interest.

51 ls), on the extraction/oxidation kinetics of low molecular weight compounds of wine brandy.

52 e an attractive method for the ionization of low molecular weight compounds over a relatively wide po

53 the adsorption and retention behaviors of a low molecular weight compound (phenol) on a C18-bonded s

54 se of the unique composition of proteins and low molecular weight compounds present in the circulator

55 tudy was to explore the relationship between low molecular weight compounds present in wines and thei

56 ignificant impact on the levels and types of low-molecular-weight compounds present.

57 ex, Supelco, Vydac, and Waters) with several low molecular weight compounds such as phenol (94 g/mol)

58 n be applied to other biologically important low-molecular weight compounds such as glucose.

59 Siderophores are low molecular weight compounds, synthesized and secreted

60 Iontophoretic injection of Neurobiotin, a low molecular weight compound that passes across most ga

61 In addition, we have also identified several low molecular weight compounds that are more efficient s

62 NMR-based screening was used to identify low molecular weight compounds that bind to this site.

63 ure was used to design a series of selective low molecular weight compounds that inhibit both plasmep

64 Besides allergens, pollen release bioactive, low molecular weight compounds that modulate and stimula

65 kage of the PA pore by a rationally designed low-molecular weight compound that prevents LF and EF en

66 SMN-C1 is a low-molecular weight compound that promotes the inclusio

67 lly and structurally similar NBD-557 are two low-molecular weight compounds that reportedly block the

68 VAF347 is a low-molecular-weight compound that inhibits allergic lun

69 index increments (RIIs) of several important low-molecular-weight compounds that bind to DNA or RNA w

70 %) during the pancreatic digestion, yielding low-molecular-weight compounds that diffused into the se

71 used a yeast two-hybrid approach to identify low-molecular-weight compounds that inhibit c-Myc-Max as

72 This cell lysis was inhibited by low-molecular-weight compounds that interfere with recep

73 F267B represents a peripherally administered low molecular weight compound to attenuate the major hal

74 en compounds to extend elemental formulas of low molecular weight compounds to those of higher molecu

75 oduced for measuring the binding kinetics of low-molecular-weight compounds to their biomolecular tar

76 e first time as a matrix for the analysis of low molecular weight compounds using matrix-assisted las

77 Plants produce diverse low-molecular-weight compounds via specialized metabolis

78 By contrast, analysis of low molecular weight compounds with this technique has b

79 tional TIR-TIR mimetics represent a class of low-molecular-weight compounds with both an antiinflamma

80 I-topoisomerase I inhibitory activity in one low molecular weight compound would constitute a unique